Anika Therapeutics ANIK reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Anika Therapeutics beat estimated earnings by 47.83%, reporting an EPS of $-0.12 versus an estimate of $-0.23.
Revenue was up $1.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.25 which was followed by a 2.24% increase in the share price the next day.
Here's a look at Anika Therapeutics's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Anika Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.